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CORONARY SINUS REDUCER
STENT
To the Editor:
I read with great interest the article
by Guenter Weigel and colleagues.1 I
want to commend the authors for their
great effort to understand the cascade
of molecular events leading to neovas-
cularization in coronary sinus inter-
ventions. However, I would like to
add some comments.
The term ‘‘Beck procedure’’ alone
is a nonspecific term inasmuch as Dr
Claude Beck has described two types
of coronary sinus interventions.2-4
The first one, the Beck I procedure,
consisted of narrowing the coronary
sinus to a diameter of 3 mm, abrading
both the epicardium and inner pericar-
dium, spilling of powdered asbestos
and 5% aqueous trichloracetic acid
on the epicardium, and placement of
mediastinal fat over the treated epicar-
dium. The second, the Beck II proce-
dure, consisted of a vascular graft
between the descending aorta and the
coronary sinus followed by operative
constriction of the coronary sinus
ostium a few weeks later. However,
both of these procedures have very
little in common with pressure-
controlled intermittent coronary sinus
occlusion (PICSO), which was studied
by the authors.
PICSO has more in common with
the coronary sinus reducer stent
(CSRS) that was developed as an alter-
native treatment for patients with re-
fractory angina pectoris.5 The CSRS
is a balloon-expandable stent that re-
duces the coronary sinus diameter to
3 mm. It is introduced into the cor-
onary sinus via the venous system,
using a percutaneous approach. Fif-
teen patients with severe angina pec-
toris have already been successfully
treated by this technology.5
Personally, I had the opportunity to
invent the Neovasc Reducer in the
mid-1990s and to lead its initial de-
velopment team until 2002. The pri-
mary idea was to increase a stenotic
coronary artery perfusion pressure
by limiting its outflow. In other
words, if we cannot increase the cor-
onary input, let’s limit or decrease its
output; instead of manipulating the
coronary arteries, let’s treat the coro-
nary veins—the upside-down strat-
egy. However, even our first study
in nonischemic pigs revealed that
8 to 12 weeks of coronary sinus
narrowing ended up with macro-
scopic epicardial new blood ves-
sels—neovascularization. This was
also seen intramyocardially. On those
days, the cascade leading from coro-
nary sinus narrowing to new macro-
scopic epicardial and intramyocardial
blood vessels was not clear enough
and some explanations other than
neovascularization were suggested.
The current study by Guenter Weigel
and colleagues sheds some light on
this subject by favoring the neoangio-
genesis explanation that is triggered
by some kind of increased coronary
sinus pressure.
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The Editor welcomes submissions for possible publica-
tion in the Letters to the Editor section that consist of
commentary on an article published in the Journal or
other relevant issues. Authors should:  Include no
more than 500 words of text, three authors, and
five references.  Type with double-spacing.  See
http://jtcs.ctsnetjournals.org/misc/ifora.shtml for de-
tailed submission instructions.  Submit the letter
electronically via jtcvs.editorialmanager.com. Let-
ters commenting on an article published in the
JTCVS will be considered if they are received within
6 weeks of the time the article was published. Au-
thors of the article being commented on will be given
an opportunity of offer a timely response (2 weeks)
to the letter. Authors of letters will be notified that
the letter has been received. Unpublished letters can-
not be returned.
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LETTERS TO THE EDITORSINGLE-STAGE VERSUS
2-STAGE REPAIR OF
COARCTATION OF THE AORTA
WITH VENTRICULAR SEPTAL
DEFECT
To the Editor:
We read with interest the article by
Walters and colleagues1 on single- ver-
sus 2-stage repair of coarctation (CoA)
with ventricular septal defect (VSD)
and congratulate the authors for excel-
lent outcomes in patients undergoing
single-stage repair of both lesions.
However, we would be very cautious
in adopting this strategy just because it
has been shown to be technically feasi-
ble and equally effective in the authors’
experience. As the authors have ac-
knowledged themselves, the study pop-
ulation comprises patients spread over
a long time frame. We may understand
here that when the surgical protocols
were developing at the authors’ institu-
tion, the authors may have elected for
a 2-stage approach over a 1-stage ap-
proach. As the protocols may have
evolved, they were able to make this
shift in strategy. However, what promp-
ted them to perform only CoA repair
combined with arch augmentation on
cardiopulmonary bypass (CPB) and
circulatory arrest leaving the VSD
open in 3 of their patients is unclear.
An important factor to be consid-
ered in developing countries is the
morbidity and the costs of the proce-
dure the patients undergo.2 Group 1
patients had a prolonged course in008
Reply to the Editor:
As Talwar and colleagues state in
their Letter to the Editor, we acknowl-
edged the obvious and unavoidable era
bias in our article. The 3 patients who
underwent repair of coarctation (CoA)
of the aorta alone, using a median ster-
notomy incision with cardiopulmo-
nary bypass, had significant proximal
aortic arch hypoplasia that precluded
satisfactory repair through a left pos-
terolateral thoracotomy incision. In
the era during which those patients
presented, we were not performing
single-stage repair of CoA with ven-
tricular septal defect (VSD).
We agree that the socioeconomic
context in which the patient with CoA-
VSD presents should be considered
when choosing the surgical strategy,
namely, single- versus 2-stage repair.
Similarly, institutional resources and
surgeon-specific variables should also
be factored into this decision. We have
documented, in our own institutional
experience, that the increased need for
delayed sternal closure has now been
neutralized1 and that the risk of media-
stinitis with delayed sternal closure,
when used, is minimal,2 but the same
may not be true in other centers.
Nonetheless, the advantages of
single-stage repair that we have clearly
documented, such as earlier age at com-
plete repair, as well as the hypothetical
advantages that we have postulated,
such as better neurodevelopmental out-
comes related to earlier complete repair,
may, in the end, transcend the economic
advantages of 2-stage repair. Therefore,
the single-stage repair of CoA-VSD
could, in the future, become a goal
worth pursuing in all centers regardless
of socioeconomic barriers. With further
research on neurodevelopmental out-
comes, the advantages of this technique
may become important enough to serve
as a stimulus for the development of re-
sources to accommodate its successful
and improved implementation.
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SOLID AND GASEOUS
CEREBRAL
MICROEMBOLIZATION AFTER
BIOLOGIC AND MECHANICAL
AORTIC VALVE
REPLACEMENT:
INVESTIGATION WITH
MULTIRANGE AND
MULTIFREQUENCY
TRANSCRANIAL DOPPLER
ULTRASOUND
To the Editor:
We read with interest the recent arti-
cle by Guerrieri Wolf and colleagues1
Letters to the Editorthe intensive care unit with a high inci-
dence of delayed sternal closure. Open
sternums do translate into a high risk
of infection in tropical countries2 and
may adversely affect the outcome.
Also with a single-stage strategy, ex-
tracorporeal membrane oxygenation
support may not always be available
if there is difficulty weaning these pa-
tients from CPB, particularly after an
extensive 2-stage procedure in a neo-
nate. Under these circumstances, if
the anatomy of the CoA is suitable
for repair and there is no need for
arch repair, a 2-stage approach can
often be justified, particularly in the
neonatal age group in whom the risk
of CPB and total circulatory arrest re-
lated complications is higher. These
patients can have the VSD closure in
a safe manner at a later stage, which
is also technically simpler in an older
patient.
In patients beyond the neonatal pe-
riod with uncomplicated CoA, we pre-
fer the single-stage approach described
by Kanter and colleagues,3 in which
the CoA is first repaired via a postero-
lateral thoracotomy, the patient is
turned supine, and the VSD is closed
using standard CPB. The advantages
of this approach are its simplicity, bet-
ter CoA management (debatable), less
CPB times, and avoidance of circula-
tory arrest. However, this strategy is
not applicable to patients with arch
hypoplasia and has the disadvantage
of 2 incisions.
In most of the public hospitals in In-
dia and other developing countries, an
initial repair of the CoA costs approx-
imately $500 and a subsequent second
stage can be accomplished at less than
$1500, but if we were to adopt a 1-
stage approach, we may incur a sub-
stantial increase in costs because of
a higher morbidity and longer inten-
sive care unit stay. Despite the claimed
advantages of a single-stage approach,
we continue to advocate the 2-stage
approach in developing countries, par-
ticularly in those centers where ‘‘profi-
ciency’’ has not been achieved in
managing these critically ill small neo-The Journanates. The authors are to be congratu-
lated on successfully achieving this.
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